Trial NCT04836832

View at ClinicalTrials.gov 
Org. Study IDs: OSU-20179
Secondary IDs: NCI-2021-01355

Last trial update was posted on 2022-06-07

MeSH Interventions

Acalabrutinib Tyrosine Kinase Inhibitors

MeSH Conditions

Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Recurrence

Other Conditions

Recurrent Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Nodal Marginal Zone Lymphoma Recurrent Splenic Marginal Zone Lymphoma Refractory Follicular Lymphoma Refractory Indolent Non-Hodgkin Lymphoma Refractory Marginal Zone Lymphoma Refractory Nodal Marginal Zone Lymphoma Refractory Splenic Marginal Zone Lymphoma

Stopping Reasons

PI decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID